|

Pembrolizumab Injectable Product Clinical Trials

1 actively recruiting trial across 1 location

Also known as: immune checkpoint inhibitor

Pipeline

Phase 1: 1

Top Sponsors

  • Baylor College of Medicine1

Indications

  • Undifferentiated Sarcoma1
  • Synovial Sarcoma1
  • HER-2 Protein Overexpression1
  • Soft Tissue Sarcoma1
  • Sarcoma1

Houston, Texas1 trial

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Texas Children's Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.